ArticleThe Journal of clinical endocrinology and metabolism2021

Lenvatinib Targets PDGFR-β Pericytes and Inhibits Synergy With Thyroid Carcinoma Cells: Novel Translational Insights.

Asumi Iesato et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.